As of 2024-12-12, the Relative Valuation of BB Biotech AG (BION.SW) is 24.89 CHF. This relative valuation is based on P/E multiples. With the latest stock price at 37.70 CHF, the upside of BB Biotech AG based on Relative Valuation is -34.0%.
The range of the Relative Valuation is 19.46 - 33.58 CHF.
| Range | Selected | |
| Trailing P/E multiples | 8.6x - 13.5x | 10.0x |
| Forward P/E multiples | 9.9x - 14.8x | 12.0x |
| Fair Price | 19.46 - 33.58 | 24.89 |
| Upside | -48.4% - -10.9% | -34.0% |
| Date | P/E |
| 2024-12-04 | 16.53 |
| 2024-12-03 | 16.48 |
| 2024-12-02 | 16.59 |
| 2024-11-29 | 16.51 |
| 2024-11-28 | 16.51 |
| 2024-11-27 | 16.42 |
| 2024-11-26 | 16.48 |
| 2024-11-25 | 16.42 |
| 2024-11-22 | 16.02 |
| 2024-11-21 | 15.89 |
| 2024-11-20 | 15.89 |
| 2024-11-19 | 15.91 |
| 2024-11-18 | 16.04 |
| 2024-11-15 | 16.42 |
| 2024-11-14 | 16.95 |
| 2024-11-13 | 17.15 |
| 2024-11-12 | 17.26 |
| 2024-11-11 | 17.61 |
| 2024-11-08 | 17.46 |
| 2024-11-07 | 17.17 |
| 2024-11-06 | 16.55 |
| 2024-11-05 | 16.31 |
| 2024-11-04 | 16.29 |
| 2024-11-01 | 16.40 |
| 2024-10-31 | 16.13 |
| 2024-10-30 | 16.24 |
| 2024-10-29 | 16.20 |
| 2024-10-28 | 16.09 |
| 2024-10-25 | 15.87 |
| 2024-10-24 | 16.51 |
| 2024-10-23 | 16.53 |
| 2024-10-22 | 16.77 |
| 2024-10-21 | 16.68 |
| 2024-10-18 | 16.51 |
| 2024-10-17 | 16.40 |
| 2024-10-16 | 16.15 |
| 2024-10-15 | 16.09 |
| 2024-10-14 | 16.17 |
| 2024-10-11 | 16.13 |
| 2024-10-10 | 15.98 |
| 2024-10-09 | 15.95 |
| 2024-10-08 | 16.06 |
| 2024-10-07 | 15.91 |
| 2024-10-04 | 15.91 |
| 2024-10-03 | 15.78 |
| 2024-10-02 | 15.87 |
| 2024-10-01 | 15.95 |
| 2024-09-30 | 16.09 |
| 2024-09-27 | 16.29 |
| 2024-09-26 | 16.22 |